Yatsen Global’s Third Quarter Net Revenue Meets Expectations, Stock Price Soars by 12%.
Yatsen BioTech will be held by COSMAX with a 51% stake and Yatsen Global with a 49% stake.
I agree to receive marketing emails from LUXEPLACE, its affiliates, and accept our terms of use and privacy policy.
✓Your new password was set.
You will receive a message with further instructions shortly to the email address you provided if it's registered with us.
Become a LUXEPLACE subscriber to unlock all exclusive content
You will receive a message with further instructions shortly to the email address you provided, find the code in it.
